Risk of limited external treatment contractors and surging treatment costs
First written in FY2018. 6 of 14 entries say "Restated". Latest entry: FY2026.
Kaname Kogyo moved to the "Worse" side of this theme in 2019, 6 years before the typical company in this theme (2025).
The whole theme swung hardest in 2026: 15 of 70 companies on the "Worse" side.
93 other companies' latest entry also says "Restated".
- FY2026RestatedAnnual report
「The Group has a limited number of external treatment contractors to which it can outsource the treatment of waste generated when disposing of waste in each business. If the financial condition of these contractors becomes unstable or treatment costs surge, this could affect the Group's operating results and financial position.」
The company continues to identify the limited number of external treatment contractors and the potential impact of surging treatment costs as risks. - FY2023RestatedAnnual report
「The Group has a limited number of external treatment contractors to which it can outsource the treatment of waste generated when disposing of waste in each business. If the financial condition of these contractors becomes unstable or treatment costs surge, this could affect the Group's operating results and financial position.」
The company continues to identify the limited number of external treatment contractors and the potential impact of surging treatment costs as risks. - FY2022-Q2MaterialisedAnnual report
「In the collection, transport and disposal business, revenue was ¥3,984.537 million, up 9.5% year on year, partly reflecting an increase in collected waste volumes and the partial pass-through to selling prices of higher waste-plastic treatment costs.」
The company states that waste plastic treatment costs have actually increased and that part of the increase was reflected in selling prices. - FY2021RestatedAnnual report
「The Group has a limited number of external treatment contractors to which it can outsource the treatment of waste generated when disposing of waste in each business. If the financial condition of these contractors becomes unstable or treatment costs surge, this could affect the Group's operating results and financial position.」
The company continues to identify the limited number of external treatment contractors and the potential impact of surging treatment costs as risks. - FY2021-Q2RestatedAnnual report
「The company continued to pursue thorough cost reductions, but was affected by a decline in waste collection volumes caused by some customers suspending operations or shortening business hours due to the spread of COVID-19, as well as fluctuations in resource prices in the industry, among other factors.」
Although there is no new disclosure on a sharp increase in treatment costs themselves, the company states that fluctuations in resource prices and other factors continued to affect results. - FY2020MaterialisedAnnual report
「The main factors were an increase of ¥88.997 million in treatment and material costs due to higher waste plastic treatment costs, an increase of ¥154.062 million in labor costs due to an increase in personnel, including workers, and an increase of ¥196.984 million in expenses due mainly to higher depreciation expenses for the Shikahama Recycling Center factory building and other facilities.」
The company states that higher waste plastic treatment costs materialized as an actual ¥88.997 million increase in treatment and material costs, resulting in higher cost of sales. - FY2020-Q3RestatedAnnual report
「In this industry, the sharp increase in waste plastic treatment costs and significant fluctuations in resource prices, including the impact of China's ban on waste resource imports, have become challenges.」
The company reconfirms the ongoing challenge of sharply rising waste plastic treatment costs against a backdrop of China's ban on waste resource imports. - FY2020-Q2WorsenedAnnual report
「In addition, against a backdrop that includes the impact of China's ban on waste plastic imports, sharply higher waste plastic treatment costs and resulting cost inflation have become challenges for the waste treatment industry.」
Regarding waste plastic treatment costs, the company identifies the sharp increase driven by China's import ban and the resulting cost inflation as a challenge, in addition to the increases and impact previously described. - FY2020-Q1MaterialisedAnnual report
「Although we continued to pursue thorough cost reductions, we were affected by higher waste plastic treatment costs and fluctuations in resource prices in this industry, among other factors.」
The company states that higher waste plastic treatment costs went beyond being a concern and actually affected results while it continued to pursue cost reductions. - FY2019MaterialisedAnnual report
「Increase in treatment and material costs of ¥420.3 million due to higher waste plastic treatment costs」
The company states that higher external treatment costs materialized as an actual increase in cost of sales, rather than remaining a concern. - FY2019-Q3MaterialisedAnnual report
「The company was affected to a considerable extent by a sharp increase in waste plastic processing costs and fluctuations in resource prices in the industry, among other factors.」
The company describes the sharp increase in waste plastic treatment costs as an actual event that affected results, rather than merely a concern about rising treatment costs. - FY2019-Q2MaterialisedAnnual report
「Waste plastic treatment costs and other costs have risen substantially.」
Previously, the company had described soaring treatment costs as a concern, but this time it reports that waste plastic treatment costs and other costs have actually risen substantially. - FY2019-Q1RestatedAnnual report
「There are also concerns, including soaring waste treatment costs,」
The company continues to recognize soaring waste treatment costs as a concern. - FY2018First statedAnnual report
「If the financial condition of these contractors becomes unstable or treatment costs surge, this could affect the Group's operating results and financial position.」
The company identifies the limited number of external treatment contractors to which waste can be outsourced, as well as changes in the contractors' financial condition and treatment costs, as risks.